{"pub": "dailymail", "url": "https://dailymail.co.uk/wires/reuters/article-7595439/U-S-FDA-approves-AstraZenecas-diabetes-drug-treating-heart-failure-risk.html", "downloaded_at": "2019-10-21 06:42:28.008980+00:00", "title": "U.S. FDA approves AstraZeneca's diabetes drug for...", "language": "en", "text": "Oct 21 (Reuters) - AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalisation for heart failure in adults with type-2 diabetes and other cardiovascular risks.\n\nThe approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the British drugmaker said and follows a similar approval https://www.astrazeneca.com/media-centre/press-releases/2019/forxiga-label-updated-in-the-eu-in-type-2-diabetes.html by the European authorities in August.\n\nDiabetes is associated with a high risk of heart failure. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)", "description": "Oct 21 (Reuters) - AstraZeneca Plc said on Monday  U.S. regulators approved its diabetes drug Farxiga to be used as  a treatment to reduce the chances of...", "authors": [], "top_image": "https://i.dailymail.co.uk/i/pix/m_logo_636x382px.png", "published_at": "2019-10-21"}